As a preeminent provider of integrated biopharmaceutical & bioengineering Process Solutions, we are dedicated to delivering end-to-end, modular process solutions that span the entire biopharmaceutical production lifecycle.
Our offerings are meticulously designed to address the critical challenges of efficiency, compliance, and safety in biopharmaceutical R&D and commercial production, empowering our clients to accelerate product development, optimize manufacturing workflows, and meet the stringent regulatory requirements of the global biopharmaceutical industry. At the core of our service philosophy lies the commitment to tailoring Process Solutions that align with the unique needs of different biopharmaceutical sectors, including vaccines, antibodies, and cell therapy, as well as adapting to diverse equipment formats such as single-use and stainless-steel systems.
Below is a detailed overview of our core modular Process Solutions, each engineered to deliver exceptional performance and reliability across every stage of biopharmaceutical production.
Our Microbial & Cell Culture Systems Process Solutions serve as the foundation for efficient biopharmaceutical production, delivering fully integrated and scalable solutions for microbial (bacteria, yeast) and cell (adherent/suspension) culture applications. Engineered to support a seamless transition from laboratory-scale R&D to commercial manufacturing, these solutions help biopharmaceutical companies accelerate time-to-market while maintaining consistent and reliable processes.
Leveraging advanced bioreactor technology, precise process control and optimized media management, our solutions ensure robust cell growth, high product yield and reproducible results, which are critical for stable and scalable bioprocessing.
For microbial culture, we provide stirred-tank and airlift bioreactors with intelligent monitoring and control systems for temperature, pH, dissolved oxygen and agitation speed, supporting the efficient production of antibiotics, insulin and other therapeutic proteins. For cell culture, our solutions accommodate both adherent and suspension cell lines, including mammalian cells for monoclonal antibodies. We offer flexible single-use bioreactors for small-scale development and durable stainless-steel systems for large-scale production, adapting to diverse capacity and budget requirements.
Furthermore, our microbial and cell culture solutions are integrated with advanced data management for real-time monitoring and full process documentation, ensuring compliance with GMP and global regulatory standards. With comprehensive, scalable and regulatory-aligned solutions, we empower our clients to focus on innovating and delivering life-saving biopharmaceutical products.
The quality and consistency of media and buffers are critical to successful biopharmaceutical production, directly influencing cell growth, product expression, and final product quality. Our Media & Buffer Preparation Systems Process Solutions provide automated, reliable, and compliant solutions for the formulation, dissolution, sterilization, and distribution of media and buffers, reducing manual operation risks and ensuring stable batch-to-batch consistency. These solutions are built to meet strict industry demands and integrate smoothly with upstream and downstream bioprocesses.
Featuring high-level automation, our systems minimize human error and enhance operational efficiency. They handle a wide range of raw materials including powders, liquids, and concentrates, with precise dosing and mixing to ensure accurate formulation based on predefined recipes. Advanced mixing technologies enable complete dissolution and uniform component distribution, while sterilization systems including SIP and gamma irradiation for single-use components ensure effective contamination control and media sterility.
Our solutions also include integrated distribution systems that deliver sterile media and buffers directly to bioreactors and upstream equipment, reducing cross-contamination risks during transfer. A centralized control system monitors and records key parameters such as temperature, pressure, mixing time, and sterilization cycles to support full regulatory compliance. Highly flexible and scalable, our systems allow easy recipe and batch size adjustments for both R&D and commercial manufacturing. We deliver consistent, high-quality media and buffer solutions to support reliable and high-performance biopharmaceutical production.
Clarification and harvest represent a critical stage in biopharmaceutical production, where target products are separated from cells, cell debris and impurities. Our Clarification & Harvest System Process Solutions deliver efficient, integrated solutions for cell harvesting and feedstock clarification, using advanced filtration and centrifugation technologies to achieve high-performance solid-liquid separation and provide high-purity feedstock for downstream processing. These solutions maximize product recovery, reduce product loss, and help clients optimize yields and lower manufacturing costs.
We offer a full range of technologies tailored to diverse cell types and production scales. For large-scale applications, our high-speed centrifuges deliver efficient separation with adjustable parameters to suit varying cell densities and viscosities, minimizing product entrainment and maximizing recovery. For clarification, our depth filtration, tangential flow filtration (TFF) and membrane filtration systems effectively remove cell debris, colloids and particulate impurities from culture supernatant.
Our systems seamlessly integrate with upstream cell culture and downstream purification processes, with modular designs that enable flexible scaling for commercial volumes. Advanced monitoring tracks key parameters including flux, pressure drop and product concentration for real-time optimization and consistent quality. All components comply with GMP standards, using biocompatible, corrosion-resistant materials. With reliable, efficient and regulatory-aligned clarification and harvest solutions, we help clients streamline workflows and secure high-quality feedstock for downstream processing.
Purification is a pivotal step in biopharmaceutical production, ensuring final products meet the stringent purity standards of global regulatory bodies. Our Purification & Filtration System Process Solutions deliver advanced, scalable solutions for product capture, polishing, and impurity removal, integrating state-of-the-art chromatography, ultrafiltration/diafiltration (UF/DF), and precision filtration technologies. Engineered for flexibility, these solutions address the unique purification challenges of monoclonal antibodies, vaccines, and cell therapy products, guaranteeing exceptional purity, yield, and stability.
At the core of our portfolio are chromatography solutions tailored to specific separation needs, including affinity, ion exchange, and hydrophobic interaction chromatography. Affinity chromatography enables high-purity capture of target proteins in a single step, while ion exchange and hydrophobic interaction chromatography excel in polishing, effectively removing host cell proteins, DNA, and aggregates. Our chromatography systems feature advanced column packing and automated process control, ensuring consistent performance and reproducible separation results across batches.
Complementing chromatography, our UF/DF systems efficiently concentrate products and facilitate buffer exchange, using semipermeable membranes to separate molecules by molecular weight and optimize feedstock for downstream processes. We also provide critical precision filtration solutions, including sterile filtration and virus filtration, to eliminate microbial and viral contaminants. Fully GMP-compliant and constructed with biocompatible, easy-to-clean materials, our modular systems integrate seamlessly with upstream and downstream workflows. This allows for smooth scaling from lab-scale R&D to large-scale commercial production, empowering clients to achieve the rigorous purity required for successful biopharmaceutical commercialization.
Viral safety is a top priority in biopharmaceutical production, mandated by global regulators and manufacturers alike. Our Virus Safety System Process Solutions are engineered to reduce viral contamination risks, integrating advanced virus filtration, chromatography, and inactivation technologies to deliver compliant, patient-safe products. These solutions meet strict viral safety standards from FDA, EMA, NMPA and other regulatory authorities, supporting reliable clinical and commercial use.
We adopt a multilayered approach to virus removal and inactivation, effectively eliminating a broad spectrum of enveloped and non-enveloped, large and small viruses. A core component is our high-performance virus filtration, using specialized membranes with precise pore sizes to retain viruses while maintaining high product recovery. Available in single-use and stainless-steel formats, our filtration systems support high throughput, large processing volumes, and minimal product loss.
Complementing filtration, we offer targeted virus inactivation methods including heat, solvent-detergent (SD), and UV treatment, customized to product characteristics and viral risks. Chromatography steps are also incorporated for additional viral clearance based on physicochemical differences between viruses and target products. All technologies are backed by comprehensive validation studies to demonstrate robust viral clearance performance.
Our virus safety solutions feature real-time process monitoring and complete traceability, with full documentation of critical parameters to support regulatory compliance. With reliable, validated viral safety solutions, we help clients minimize contamination risks, protect patient safety, and achieve successful commercialization in the global biopharmaceutical market.
A clean, safe manufacturing environment is essential to ensure biopharmaceutical product quality, safety, and GMP compliance. Our Cleaning & Waste Inactivation System Process Solutions deliver integrated, efficient solutions for clean-in-place (CIP) and bio-waste inactivation, minimizing cross-contamination risks and enabling compliant waste management. These solutions are tailored to the unique needs of biopharmaceutical facilities, integrating seamlessly with production workflows and reducing operational burdens.
At the core is our automated CIP system, designed for reliable cleaning of bioreactors, tanks, pipelines, and production equipment without manual disassembly. Using optimized cleaning agents, temperature, and flow rates, the system effectively removes residues, cell debris, and contaminants to ensure thorough sanitization between batches. Fully automated and centrally controlled, it monitors and records key parameters including cleaning time, temperature, and chemical concentration to support consistent GMP compliance. Our CIP solutions are available in single-use and stainless-steel configurations, adaptable to diverse equipment and process requirements.
Complementing CIP, our bio-waste inactivation systems safely treat hazardous waste such as cell culture waste, spent media, and process effluents. Utilizing heat, chemical, and steam sterilization technologies, these systems eliminate microbial contaminants and reduce environmental impact. Fully integrated with production, they enable timely and efficient waste handling to lower cross-contamination and pollution risks. All components are GMP-compliant, corrosion-resistant, and compatible with standard cleaning agents and waste streams.
With efficient, regulatory-aligned cleaning and waste inactivation solutions, we help clients maintain a safe manufacturing environment, minimize contamination risks, and sustain full compliance with global biopharmaceutical standards.
We recognize that every biopharmaceutical company has unique production requirements, based on product type (vaccines, antibodies, cell therapy), production scale, and equipment format (single-use or stainless‑steel). All our Process Solutions are fully customizable, with modular designs that can be adapted to meet your specific operational and regulatory needs. Our team of experienced biopharmaceutical engineers and process specialists works closely with you to understand your goals and challenges, delivering tailored solutions that optimize workflows, reduce costs, and accelerate time‑to‑market.
For vaccine manufacturers, we customize microbial & cell culture systems and purification & filtration solutions to support specific strains and meet strict vaccine purity standards. For cell therapy applications, we provide single‑use process solutions that minimize cross‑contamination and support small‑scale, personalized production. For clients using stainless‑steel facilities, we deliver robust, easy‑to‑clean, and highly scalable systems for large‑scale commercial manufacturing.
Our customization support extends beyond initial design and implementation. We provide ongoing service and process optimization to help you adapt to evolving production demands, whether scaling up, launching new products, or complying with updated regulations. With flexible, tailored Process Solutions, we help you maintain competitiveness in the global biopharmaceutical industry and achieve long‑term production and commercial success.
Our Process Solutions stand out for their superior integration, efficiency, compliance, and flexibility, making us a trusted partner for biopharmaceutical companies worldwide. We provide comprehensive, end-to-end, modular solutions that seamlessly integrate across the entire biopharmaceutical production lifecycle, improving process efficiency, reducing costs and lead times, while ensuring full compliance with global regulatory standards.
Backed by a professional team with deep expertise in bioprocess engineering, regulatory compliance and project management, we deliver solutions engineered to the highest industry standards. We partner with you throughout the entire project lifecycle — from consultation, design and installation to validation and ongoing support — to provide personalized, reliable service tailored to your unique needs.
In short, our advanced Process Solutions help you overcome key biomanufacturing challenges, supporting both R&D and commercial-scale production. Whether you are developing vaccines, antibodies, cell therapies or optimizing existing workflows, we deliver the robust, compliant and flexible solutions to drive your success.
Copyright © 2026 by Shanghai Ritai Medicine Equipment Project Co., Ltd. - Privacy policy